James E. Hosch

Director/Miembro de la Junta en Arrogene, Inc. .

71 años

Finance

Consumer Services

Health Technology

Perfil

James E.
Hosch is currently a Director at Arrogene, Inc. He was previously a Managing Director at WestPark Capital, Inc. He obtained an undergraduate degree from Texas A&M University.

Cargos activos de James E. Hosch

Empresas	Cargo	Inicio
Arrogene, Inc. Arrogene, Inc. Pharmaceuticals: MajorHealth Technology Arrogene, Inc. commercializes a cancer treatment technology and a proprietary molecular delivery platform. Its technology delivers peptide, protein and oligonucleotide therapeutics across the blood-brain barrier to cancer cells to prevent tumor growth or for imaging. The company was founded by Julia Ljubimova, Alexander Ljubimova, Keith Black and Eggehard Holler in 2006 and is headquartered in Los Angeles, CA.	Director/Miembro de la Junta	13/05/2016

Todos los cargos activos de James E. Hosch

Antiguos cargos conocidos de James E. Hosch.

Empresas	Cargo	Fin
WestPark Capital, Inc. WestPark Capital, Inc. Investment ManagersFinance WestPark Capital, Inc. (WPC) is a SEC-registered investment advisor headquartered in Los Angeles, California. The firm was founded by Richard Rappaport in 1999 and is a subsidiary of Westpark Capital Group LLC. WPC offers investment services to individual and institutional investors.	Gestor de Cartera-Acciones	-

Ver el detalle de la experiencia de James E. Hosch.

Formación de James E. Hosch.

Texas A&M University

Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de James E. Hosch.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	2
WestPark Capital, Inc. WestPark Capital, Inc. Investment ManagersFinance WestPark Capital, Inc. (WPC) is a SEC-registered investment advisor headquartered in Los Angeles, California. The firm was founded by Richard Rappaport in 1999 and is a subsidiary of Westpark Capital Group LLC. WPC offers investment services to individual and institutional investors.	Finance
Arrogene, Inc. Arrogene, Inc. Pharmaceuticals: MajorHealth Technology Arrogene, Inc. commercializes a cancer treatment technology and a proprietary molecular delivery platform. Its technology delivers peptide, protein and oligonucleotide therapeutics across the blood-brain barrier to cancer cells to prevent tumor growth or for imaging. The company was founded by Julia Ljubimova, Alexander Ljubimova, Keith Black and Eggehard Holler in 2006 and is headquartered in Los Angeles, CA.	Health Technology